| Literature DB >> 35265887 |
Ulla Walfridsson1, David Brohede2, Håkan Walfridsson1.
Abstract
Background: In the structured care of patients with atrial fibrillation (AF), education is compulsory. Patients search for information but sources of reliable information are sparse. ASK FOR IT, an internet- and guideline-based educational program, offers such information. Objective: To describe the development of ASK FOR IT, report on a pilot study, and present the design of a randomized controlled trial evaluating the benefits of ASK FOR IT in addition to standard care on symptoms, health-related quality of life (HRQoL), and health economy.Entities:
Keywords: Atrial fibrillation; Disease-specific questionnaire; Health-related quality of life; Internet-based education; Structured care; Symptoms
Year: 2020 PMID: 35265887 PMCID: PMC8890055 DOI: 10.1016/j.cvdhj.2020.11.003
Source DB: PubMed Journal: Cardiovasc Digit Health J ISSN: 2666-6936
Content overview
| Module/Step | Content | Exercises |
|---|---|---|
| 1: Mechanism of AF | Basic knowledge about the well-functioning heart, ECG, AF, symptoms, influence on daily life concerns and possible causes. | Mapping out personal symptoms and life impact. |
| 2: Tests and diagnostics | Information about the most common diagnostic tools and their procedures. Introduction to diagnostic scales such as CHA2DS2VASc and EHRA scores. | CHA2DS2VASc estimation, BMI scoring, personal experiences from debut, diagnostics and previous treatment. |
| 3: Treatments of AF: drugs and cardioversion | Overview of medication options and cardioversion. | Previous medication, side effects, and planned follow-up. |
| 4: Treatments of AF: ablation and other treatments | Overview of treatment principles in ablation and other options. | Previous treatments including ablation pacemaker and surgical treatments. Side effects and planned follow-up. |
| 5: The significance of lifestyle | Factors influencing impact severity, including weight loss, sleep, tobacco use, and other possible self-help actions. | Personal goal-setting concerning lifestyle. |
| 6: Living with AF | Research-based information on experiences of AF's impact on everyday life. Acceptance- and commitment-inspired focus on acceptance of factors outside the patient's control and commitment to choices within the patient's control. | Mapping of strategies used by the patient to cope with the situation, including selection of constructive coping strategies. Evaluation of the program itself. |
AF = atrial fibrillation; BMI = body mass index; EHRA = European Heart Rhythm Association.
Patient characteristics
| Number of patients | 15 |
| Age (years), mean (range) | 64.7 (39–82) |
| Sex (women) | 4 |
| Sex (men) | 11 |
| Body mass index (kg/m2), mean (± SD) | 27.8 (± 4.5) |
| Paroxysmal AF | 9 |
| Persistent AF | 4 |
| Permanent AF | 2 |
| Congestive heart failure | 0 |
| Hypertension | 7 |
| Diabetes | 2 |
| TIA/stroke | 1 |
| Vascular disease | 1 |
| Ischemic heart disease | 1 |
| CHA2DS2VASc | |
| 0 | 5 |
| 1 | 2 |
| 2 | 1 |
| 3 | 3 |
| 4 | 4 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| Antiarrhythmic drugs | |
| Beta blockers | 10 |
| Calcium antagonists | 0 |
| Digitalis | 0 |
| Class 1A | 0 |
| Class 1C | 1 |
| Class III sotalol | 0 |
| Amiodarone | 3 |
| Dronedarone | 0 |
| Anticoagulants | |
| Warfarin | 5 |
| NOAC | 7 |
NOAC = new oral anticoagulants; TIA = transient ischemic attack.
Class IA and IC: Classification according to Vaughan Williams for antiarrhythmic drugs; no patient was on calcium antagonists, digitalis, class IA, sotalol, or dronedarone.
Details on each participating patient
| Age | Sex | AF history (years) | AF type | EHRA score | BMI | CHA2DS2VASc | Congestive heart failure | Hypertension | Diabetes | Vascular disease | Ischemic heart disease | TIA/stroke | β-blocker | Class 1C | Amiodarone | Warfarin | NOAG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient 1 | 82 | M | 10 | Permanent | 2b | 34 | 4 | 0 | X | 0 | X | 0 | 0 | X | 0 | 0 | X | 0 |
| Patient 2 | 80 | M | 9 | Permanent | 3 | 28 | 3 | 0 | X | 0 | 0 | 0 | 0 | X | 0 | 0 | X | 0 |
| Patient 3 | 79 | M | 34 | Paroxysmal | 2b | 25 | 4 | 0 | X | 0 | 0 | X | 0 | 0 | 0 | X | X | 0 |
| Patient 4 | 79 | F | 2 | Persistent | 4 | 24 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | X | 0 | X | 0 | X |
| Patient 5 | 75 | F | 9 | Paroxysmal | 3 | 32 | 4 | 0 | X | 0 | 0 | 0 | 0 | X | 0 | 0 | X | 0 |
| Patient 6 | 73 | F | 9 | Persistent | 3 | 27 | 4 | 0 | X | X | 0 | 0 | 0 | X | 0 | 0 | X | 0 |
| Patient 7 | 65 | M | 12 | Paroxysmal | 3 | 31 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | X |
| Patient 8 | 63 | M | 7 | Paroxysmal | 1 | 24 | 2 | 0 | X | X | 0 | 0 | 0 | 0 | 0 | 0 | 0 | X |
| Patient 9 | 60 | M | 2 | Paroxysmal | 2b | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | X | X | 0 | 0 | X |
| Patient 10 | 59 | M | 10 | Persistent | 3 | 24 | 3 | 0 | X | 0 | 0 | 0 | X | X | 0 | X | 0 | X |
| Patient 11 | 57 | F | 14 | Paroxysmal | 3 | 37 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | X |
| Patient 12 | 55 | M | 2 | Paroxysmal | 3 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | X | 0 | 0 | 0 | 0 |
| Patient 13 | 55 | M | <1 | Paroxysmal | 3 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | X | 0 | 0 | 0 | 0 |
| Patient 14 | 50 | M | <1 | Persistent | 4 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | X | 0 | 0 | 0 | X |
| Patient 15 | 39 | M | 20 | Paroxysmal | 3 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AF = atrial fibrillation; BMI = body mass index; EHRA = European Heart Rhythm Association; NOAC = new oral anticoagulants; TIA = transient ischemic attack.
Class IA and IC: Classification according to Vaughan Williams for antiarrhythmic drugs; no patient was on calcium antagonists, digitalis, class IA, sotalol, or dronedarone.
This patient did not complete the study.
The 9 individual items in the ASTA symptom scale
| Item | Symptom |
|---|---|
| 1 | Breathlessness during activity |
| 2 | Breathlessness even at rest |
| 3 | Dizziness |
| 4 | Cold sweats |
| 5 | Weakness/fatigue |
| 6 | Tiredness |
| 7 | Chest pain |
| 8 | Pressure/discomfort in chest |
| 9 | Worry/anxiety |
The 13 individual items in the ASTA health-related quality-of-life scale
| Item | Subscale |
|---|---|
| Do you feel unable to work, study or carry out daily activities as you would like to due to your arrhythmia? | Physical |
| Do you spend less time with your family/relatives and friends than you would like to due to your arrhythmia? | Physical |
| Do you spend less time with acquaintances (people you do not know that well) than you would like to due to your arrhythmia? | Physical |
| Do you avoid planning things you would like to do, for instance travelling or leisure activities due to your arrhythmia? | Physical |
| Is your physical ability impaired due to your arrhythmia? | Physical |
| Is your ability to concentrate impaired due to your arrhythmia? | Mental |
| Do you feel dejected or sad due to your arrhythmia? | Mental |
| Do you feel irritated or angry due to your arrhythmia? | Mental |
| Do you experience sleep problems due to your arrhythmia? | Mental |
| Is your sexual life affected negatively by your arrhythmia? | Physical |
| Are you afraid of dying due to your arrhythmia? | Mental |
| Has your life situation deteriorated due to your arrhythmia? | Physical |
| Do you feel worried that your symptoms will re-occur during the periods when you do not have arrhythmia? | Mental |
Overall scoring in the ASTA symptom and health-related quality-of-life scales
| Mean (baseline) | SD (baseline) | Mean (3 months) | SD (3 months) | Sig (2-tailed) (3 months) | Cohen’s d (ES) | |
|---|---|---|---|---|---|---|
| Symptom score 9 items | 31.93 | 9.98 | 21.43 | 15.01 | .038 | 0.62 |
| HRQoL total score 13 items | 26.71 | 17.95 | 20.21 | 17.06 | .189 | |
| Physical score 7 items | 28.93 | 22.52 | 23.57 | 25.30 | .440 | |
| Mental score 6 items | 23.50 | 14.83 | 14.79 | 9.93 | .011 | 0.79 |
ES = effect size; HRQoL = health-related quality of life; Sig = significance.
Small 0.2, medium 0.5, large 0.8.
Figure 1Flow chart for the prospective, randomized control study ASK FOR IT. AA treatment = antiarrhythmic medication; AF = atrial fibrillation; ASTA = arrhythmia-specific questionnaire in tachycardia and arrhythmia; BMI = body mass index; ECG = electrocardiogram; EQ-5D = EuroQuol 5 dimensions; HADS = Hospital Anxiety and Depression Scale; HRQoL = health-related quality of life; RCT = randomized controlled study; SF-36 = The Medical Outcomes Study 36-Item Short Form Health Survey.